Clinical Site Partners Orlando, Miami, Leesburg, Florida A NETWORK OF RESEARCH SITES CONDUCTING PHASE I-IV CLINICAL TRIALS Find a Research Site Near You  

Clinical Research Network Serving Florida

Sponsor / CRO Info

A large network of experienced investigators clinical research facilities, successful patient recruitment and retention strategies, and more.

Therapeutic Areas We Research

Women’s Health, Cardiology, Vaccines, Dermatology, Nephrology, Pediatric Pulmonology, and More!

Clinical Research Blog

President Trump Received Experimental Antibody Treatment

President Trump Received Experimental Antibody Treatment

Mr. Trump received a single dose of an antibody cocktail made by the biotech company Regeneron. The company’s C.E.O. has known the president for years. President Trump has received a dose of an experimental antibody cocktail being developed by the drug maker Regeneron, in addition to several other drugs, including zinc, vitamin D and the

Read More »
Experts think monoclonal antibodies could be best option for COVID-19 treatment

Experts think monoclonal antibodies could be best option for COVID-19 treatment

The Washington Post (9/30, A1, Johnson) reports many experts think a drug, called a monoclonal antibody cocktail, “could be the best bet to defang the novel coronavirus and transform it from a potentially lethal infection into a treatable illness.” NIH Director Francis Collins said it is “a real best chance of being a game changer.” Meanwhile, Janet Woodcock,

Read More »
Regeneron Antibody Cocktail Lowers Virus in Covid Patients coronavirus covid-19

Regeneron Antibody Cocktail Lowers Virus in Covid Patients

A Regeneron Pharmaceuticals Inc. antibody cocktail may help treat coronavirus patients outside of the hospital by reducing virus levels and symptoms, early study results indicate. In an early-stage clinical trial of 275 Covid-19 patients, those who received Regeneron’s experimental therapy had lower virus levels in the bloodstream seven days later compared with patients who received a placebo,

Read More »